mRNA |
GDC-0941 |
gCSI |
pan-cancer |
AAC |
-0.0031 |
1 |
mRNA |
CIL56 |
CTRPv2 |
pan-cancer |
AAC |
0.0024 |
1 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0016 |
1 |
mRNA |
BRD-K29086754 |
CTRPv2 |
pan-cancer |
AAC |
-0.0037 |
1 |
mRNA |
istradefylline |
CTRPv2 |
pan-cancer |
AAC |
0.0026 |
1 |
mRNA |
erlotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0017 |
1 |
mRNA |
TGX221 |
GDSC1000 |
pan-cancer |
AAC |
0.0022 |
1 |
mRNA |
navitoclax:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0015 |
1 |
mRNA |
selumetinib:decitabine (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0014 |
1 |
mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0015 |
1 |